| Category : |
Pharmaceuticals and Biochemicals |
 |
| CAS NO : |
179324-69-7 |
| EC NO : |
|
| MF : |
C19H25BN4O4 |
| MW : |
384.2372 |
| Packing : |
1kgs |
| Product description : |
[(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid
BORTEZOMIB
dpba
VELCADE
VELCADE(BORTEZOMIB)
Boronic acid, B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-
Bortezomib for research
【CAS】
179324-69-7
【中文名稱】
[(1R)-3-甲基-1-[[(2S)-1-氧-3-苯基-2-[(吡嗪甲酰)氨基]丙基]氨基]丁基]-硼酸
保特佐米
硼替佐米
【分子式】
C19H25BN4O4
【MDL 編號】
MFCD05260688
384.24
|
| Uses : |
Malignant tumor treatment |
| Synonyms : |
VELCADE;dpba;[(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid;VELCADE(BORTEZOMIB);Boronic acid, B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-;Bortezomib for research;N-[(1S)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-D-phenylalaninamide;N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide;Bortizomib; |
| Molecular Structure : |
 |